At-Home Telemedicine
The Eko DUO is the first combined digital stethoscope and 1-lead ECG device designed specifically for patients to operate at home, under the supervision of a healthcare provider. With Eko’s easy-to-use mobile application, patients at home can connect via video conference with their providers and navigate a self-operated cardiac and pulmonary exam. For COVID-19 cases being monitored remotely, Eko helps providers assess worsening symptoms while reducing the need for patients to travel to a medical site and risk exposure or continued spread of COVID-19.
“During the COVID-19 crisis it is no longer safe to send our nurses into patient homes, and this required us to rethink our house call model. Eko has introduced us to new technologies that we can safely share with patients to examine them remotely. Eko Telehealth enables us to use the DUO stethoscope, 1-lead ECG and video with the patient all in one window, making it possible to conduct thorough virtual visits on high-risk patients,” said Dr. Neil Solomon, co-founder, Chief Strategist and Chief Medical Officer at MedZed.
About Eko
Eko is elevating the way clinicians detect and monitor cardiac and respiratory disease by bringing together advanced sensors, patient and provider software, and AI-powered analysis. Its FDA cleared platform is used by tens of thousands of clinicians treating millions of patients around the world, in-person, and through telehealth. The company is headquartered in Oakland, California and privately-held, with investments from ARTIS Ventures, NTT Venture Capital, DigiTx Ventures, Mayo Clinic, Sutter Health and others.
Back to HCB News
